Evidence map›Paper›PMID 42438730›Full record

ArticleMaterials today. Bio2026

Biphasic oxygen-regulating cyanobacterial hydrogel for synergistic ischemic stroke gas therapy and post-stroke depression prevention.

Haoxin Cheng, Haihua Yang, Hongmei Liu, Yihan Luo, Zhihao Zhou, Mengzhen Zhao, Chao Wang, Zhiyan Xiong, Shichen Liu, Xiaolei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haoxin ChengSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330036, PR China.
Haihua YangSchool of the First Clinical Medicine, Nanchang University, Nanchang, 330036, PR China.
Hongmei LiuSchool of the First Clinical Medicine, Nanchang University, Nanchang, 330036, PR China.
Yihan LuoAffiliated Stomatological Hospital, Nanchang University, Nanchang, 330006, PR China.
Zhihao ZhouSchool of the First Clinical Medicine, Nanchang University, Nanchang, 330036, PR China.
Mengzhen ZhaoSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330036, PR China.
Chao WangInstitute of Translational Medicine, Nanchang University, Nanchang, 330036, PR China.
Zhiyan XiongSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330036, PR China.
Shichen LiuDepartment of Vascular Surgery, The Second Affiliated Hospital, Nanchang University, Nanchang, 330006, PR China.
Xiaolei WangSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, 330036, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic stroke (87% of stroke cases) results from cerebral artery occlusion. Reperfusion therapy restores cerebral blood flow but predisposes to dual complications: ischemia-reperfusion injury (IRI) caused by oxygen fluctuations exacerbating neural damage and post-stroke depression (PSD). This study develops a cyanobacteria hydrogel composite (PT-CUCBD) for comprehensive reperfusion protection through precisely regulating the oxygen (O

Indexed as

CyanobacteriaIschemic strokeNear-infrared irradiationPost-stroke depressionUpconversion nanoparticle

Identifiers

PMID42438730
PMCPMC13356774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.